These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23104617)

  • 1. Brief Report: social disability in autism spectrum disorder: results from Research Units on Pediatric Psychopharmacology (RUPP) Autism Network trials.
    Scahill L; Hallett V; Aman MG; McDougle CJ; Eugene Arnold L; McCracken JT; Tierney E; Deng Y; Dziura J; Vitiello B;
    J Autism Dev Disord; 2013 Mar; 43(3):739-46. PubMed ID: 23104617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of the modified Children's Yale-Brown Obsessive Compulsive Scale to detect change: Results from two multi-site trials.
    Scahill L; Sukhodolsky DG; Anderberg E; Dimitropoulos A; Dziura J; Aman MG; McCracken J; Tierney E; Hallett V; Katz K; Vitiello B; McDougle C
    Autism; 2016 Feb; 20(2):145-52. PubMed ID: 25882391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.
    McDougle CJ; Scahill L; Aman MG; McCracken JT; Tierney E; Davies M; Arnold LE; Posey DJ; Martin A; Ghuman JK; Shah B; Chuang SZ; Swiezy NB; Gonzalez NM; Hollway J; Koenig K; McGough JJ; Ritz L; Vitiello B
    Am J Psychiatry; 2005 Jun; 162(6):1142-8. PubMed ID: 15930063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders.
    McDougle CJ; Holmes JP; Carlson DC; Pelton GH; Cohen DJ; Price LH
    Arch Gen Psychiatry; 1998 Jul; 55(7):633-41. PubMed ID: 9672054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.
    Asadabadi M; Mohammadi MR; Ghanizadeh A; Modabbernia A; Ashrafi M; Hassanzadeh E; Forghani S; Akhondzadeh S
    Psychopharmacology (Berl); 2013 Jan; 225(1):51-9. PubMed ID: 22782459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors and moderators of parent training efficacy in a sample of children with autism spectrum disorders and serious behavioral problems.
    Farmer C; Lecavalier L; Yu S; Eugene Arnold L; McDougle CJ; Scahill L; Handen B; Johnson CR; Stigler KA; Bearss K; Swiezy NB; Aman MG
    J Autism Dev Disord; 2012 Jun; 42(6):1037-44. PubMed ID: 21822762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
    Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials.
    Arnold LE; Vitiello B; McDougle C; Scahill L; Shah B; Gonzalez NM; Chuang S; Davies M; Hollway J; Aman MG; Cronin P; Koenig K; Kohn AE; McMahon DJ; Tierney E
    J Am Acad Child Adolesc Psychiatry; 2003 Dec; 42(12):1443-50. PubMed ID: 14627879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. l-Carnosine As an Adjunctive Therapy to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Hajizadeh-Zaker R; Ghajar A; Mesgarpour B; Afarideh M; Mohammadi MR; Akhondzadeh S
    J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):74-81. PubMed ID: 29027815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH; Merry SN; Hetrick SE; Stasiak K
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008559. PubMed ID: 28791693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examination of aggression and self-injury in children with autism spectrum disorders and serious behavioral problems.
    Carroll D; Hallett V; McDougle CJ; Aman MG; McCracken JT; Tierney E; Arnold LE; Sukhodolsky DG; Lecavalier L; Handen BL; Swiezy N; Johnson C; Bearss K; Vitiello B; Scahill L
    Child Adolesc Psychiatr Clin N Am; 2014 Jan; 23(1):57-72. PubMed ID: 24231167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of risperidone in children with autism spectrum disorder.
    Chavez B; Chavez-Brown M; Rey JA
    Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder.
    Rezaei V; Mohammadi MR; Ghanizadeh A; Sahraian A; Tabrizi M; Rezazadeh SA; Akhondzadeh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1269-72. PubMed ID: 20637249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone Combination Therapy With Propentofylline for Treatment of Irritability in Autism Spectrum Disorders: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Behmanesh H; Moghaddam HS; Mohammadi MR; Akhondzadeh S
    Clin Neuropharmacol; 2019; 42(6):189-196. PubMed ID: 31725473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and tolerability of switching to aripiprazole from risperidone in subjects with autism spectrum disorders: a prospective open-label study.
    Ishitobi M; Kosaka H; Takahashi T; Yatuga C; Asano M; Tanaka Y; Ueno K; Okazaki R; Omori M; Hiratani M; Tomoda A; Wada Y
    Clin Neuropharmacol; 2013; 36(5):151-6. PubMed ID: 24045605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled study of risperidone maintenance treatment in children and adolescents with disruptive behavior disorders.
    Reyes M; Buitelaar J; Toren P; Augustyns I; Eerdekens M
    Am J Psychiatry; 2006 Mar; 163(3):402-10. PubMed ID: 16513860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind placebo controlled trial of Ginkgo biloba added to risperidone in patients with autistic disorders.
    Hasanzadeh E; Mohammadi MR; Ghanizadeh A; Rezazadeh SA; Tabrizi M; Rezaei F; Akhondzadeh S
    Child Psychiatry Hum Dev; 2012 Oct; 43(5):674-82. PubMed ID: 22392415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months.
    Research Units on Pediatric Psychopharmacology Autism Network
    Am J Psychiatry; 2005 Jul; 162(7):1361-9. PubMed ID: 15994720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No Apparent Cardiac Conduction Effects of Acute Treatment with Risperidone in Children with Autism Spectrum Disorder.
    Vo LC; Snyder C; McCracken C; McDougle CJ; McCracken JT; Aman MG; Tierney E; Arnold LE; Levi D; Kelleman M; Carroll D; Morrissey J; Vitiello B; Scahill L
    J Child Adolesc Psychopharmacol; 2016 Dec; 26(10):900-908. PubMed ID: 27726426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial severity and efficacy of risperidone in autism: Results from the RUPP trial.
    Levine SZ; Kodesh A; Goldberg Y; Reichenberg A; Furukawa TA; Kolevzon A; Leucht S
    Eur Psychiatry; 2016 Feb; 32():16-20. PubMed ID: 26802979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.